| 摘要 |
<p>Disclosed is ringlike flavone shown by the formula (I), or an isoflavone compound, or nitric oxide, hydrate, solvate, or metabolite thereof, or pharmaceutically accepted salt or prodrug. A2 is -O- when A is -C(O)-; A2 is -C(O)- when A is -O-; Q is -O-、-S-、-C(R4R5)-、-C(R4R5)O-、-OC(R4R5)-、-C(R4R5)N(R6)-、-N(R6)C(R4R5)-、-N(R6)-、-C(R4R5)C(R4R5)-、-C(R4R5)-S- or -S-C(R4R5)-; W is -(NHC(O))1~2-、-(C1-C3) alkylene-(NHC(O))1~2-, formula (II), formula (III),formula (IV), or formula (V); or R1 is connected to W to form the imidazole ring. The ringlike flavone or isoflavone compound of the present invention has a desirable anti-hepatitis C virus effect.</p> |
